Extracellular matrix substrates contribute to both uterine and blastocyst functions during the peri-implantation period. Tubulointerstitial nephritis antigen-like 1 (TINAGL1, also known as adrenocortical zonation factor 1 [AZ-1] or lipocalin 7) is a novel matricellular protein that promotes cell adhesion and spreading. However, the physiological roles of TINAGL1 are still not clearly understood. We examined the expression and localization of TINAGL1 in peri-implantation mouse uteri. During the preimplantation period, TINAGL1 was expressed in the basement membranes of uterine luminal epithelial cells on Days 1 and 2 of pregnancy, while its expression levels declined after Day 3. In the whole uteri, the expression levels of Tinagl1 mRNA and TINAGL1 protein were similar on Days 1-4 of pregnancy. In contrast, the expression of Tinagl1 mRNA and TINAGL1 protein increased in postimplantation uteri. From Days 6 to 8, TINAGL1 was markedly expressed in the decidual endometrium. TINAGL1 is a ligand for integrins and promotes cell adhesion in cultured cells. Therefore, to address whether TINAGL1 interacts with integrins in the uterus, immunohistochemical analysis and immunoprecipitation were performed. Immunohistochemical analysis showed that ITGA2, ITGA5, and ITGB1 were expressed in stromal cells around the implanted embryos on Days 7 and 8. Biacore and immunoprecipitation analysis determined that TINAGL1 linked with ITGA5 and ITGB1 in the decidual endometrium. These results suggest that Tinagl1 functions during the postimplantation period; in particular, it associates with ITGA5B1 in the decidualized uterine endometrium. decidua, female reproductive tract, implantation, pregnancy, uterus
INTRODUCTION
In mammalian reproduction, cross talk between the blastocyst and the uterine luminal epithelium is essential to the implantation process [1] . Synchronized differentiation of the uterus to the receptive state and the development of embryos are necessary to complete this step. The receptivity of the uterus for implantation lasts for a limited period, and it supports blastocyst growth, attachment, and the subsequent events of implantation [2, 3] . During peri-implantation, the coordinated actions of progesterone and estrogen regulate the proliferation and/or differentiation of uterine cells in a spatiotemporal manner to establish the window of implantation in mice [4] . On the first day of pregnancy (vaginal plug), uterine epithelial cells proliferate under the influence of preovulatory estrogen secretion. Rising levels of progesterone secreted from freshly formed corpora lutea initiate stromal cell proliferation from Day 3 onward. Stromal cell proliferation is further stimulated by a small amount of ovarian estrogen secreted on the morning of Day 4. After the attachment, stromal cells surrounding the implanting blastocyst begin to proliferate extensively and differentiate into decidual cells (decidualization) [3] . The proliferation and differentiation of uterine endometrial cells are crucial steps during peri-implantation. Many factors such as the extracellular matrix, adhesion molecules, lipid mediators, and transcription factors are involved in this process; however, the molecular pathways are not clearly understood because of their intricacy.
Extracellular proteins that do not contribute directly to the formation of structural elements in vertebrates but serve to modulate cell-matrix interactions and cell function are categorized as matricellular proteins [5] . The mouse ortholog of tubulointerstitial nephritis antigen-like 1 (Tinagl1, also known as adrenocortical zonation factor 1 [AZ-1] or lipocalin 7) was cloned from mouse adrenocortical cells and is tightly linked with the zonal differentiation of adrenocortical cells [6] . TINAGL1 is a novel matricellular protein that interacts with both structural matrix proteins and cell surface receptors [7] . The findings that in cultured cells TINAGL1 is a ligand for integrins-including a1b1 (ITGA1B1), a2b1 (ITGA2B1), and a5b1 (ITGA5B1)-and promotes cell adhesion suggest that this protein is involved in the regulation of the intracellular signaling that determines cellular functions.
Among the adhesion molecules, integrins have been studied more extensively in the human endometrium because of their cycle-dependent changes and their potential role in uterine receptivity. The members of the integrin family serve as receptors for various extracellular matrix ligands and modulate cell-cell adhesion and signal transduction events [8] . Each integrin is composed of two subunits, ITGA (a chain) and ITGB (b chain), and each heterodimer combination has its own binding specificity and signaling properties. Signaling by integrins is mediated by their association with adaptor proteins that bridge them to the cytoskeleton, cytoplasmic kinases, and transmembrane growth factor receptors [8] . In humans, the regulatory pathways for controlling the expression of integrins in the endometrium have been widely investigated [9] . In contrast, the function of integrins in the mouse uterus is still poorly understood, although it has been reported that some integrins are associated with endometrial regulation [10] [11] [12] .
The present study focused on whether Tinagl1 is related to the reproductive role in the uterus during peri-implantation. The expression and localization of Tinagl1 in the preimplantation and postimplantation mouse uterus were examined first. The expression of both mRNA and protein was increased in the postimplantation uteri. During postimplantation, TINAGL1 was expressed markedly in the decidualized endometrium. It has been reported that TINAGL1 is a ligand for integrins in a cell culture system [7] . Therefore, we hypothesized that TINAGL1 associates with integrins in the postimplantation uteri. Our results demonstrated that TINAGL1 is linked with ITGA5 and ITGB1 in uterine decidualized endometrium in the mouse.
MATERIALS AND METHODS

Animals and Collection of Uterine Tissues
ICR mice were purchased from Japan SLC, Inc. (Shizuoka, Japan) and bred in our animal care facility. The experimental procedures were performed in accord with the instructions of the Guide for the Care and Use of Laboratory Animals published by Utsunomiya University. Female mice were mated with fertile males, and pregnancy (Days 1-4, with vaginal plug denoting Day 1) was confirmed by recovering embryos from the reproductive tracts. During postimplantation on Days 5-8, the implantation site was collected. Decidualized endometrium was isolated from Day 8 uteri as described previously [13] . Uterine tissues were snap frozen and stored at À808C until use for real-time RT-PCR, Western blot analysis, immunohistochemical analysis, Biacore (Biacore X; GE Healthcare Bio-Sciences KK, Tokyo, Japan) analysis, and immunoprecipitation.
Real-Time RT-PCR
Real-time RT-PCR was performed as previously described [14] , with slight modifications. Total RNA was extracted from uteri with RNAqueous (Ambion, Austin, TX) according to the manufacturer's instructions. Complementary DNA was synthesized using high-capacity cDNA RT kits (Applied Biosystems, Foster City, CA). Real-time RT-PCR reactions were performed using the SYBR green PCR kit (Qiagen, Hilden, Germany) on an ABI 7500 real-time PCR system (Applied Biosystems) according to the manufacturer's instructions. Levels of Tinagl1 relative to those of Gapdh were determined. Primer sets for Tinagl1, as well as control genes for expression of Gapdh, were designed as follows:
0 (forward), and Gapdh 5 0 -CACACCCAT CACAAACATGG-3 0 (reverse). Primers were validated by RT-PCR and agarose gel electrophoresis before use. Real-time RT-PCR was performed in a 25-ll reaction volume using 100 ng of cDNA. Samples were cycled for 15 sec at 948C, 30 sec at 578C, and 35 sec at 728C for 45 cycles. Data were analyzed using 7500 SDS software with the DDCt method (Applied Biosystems). Experiments were repeated three times.
Western Blot Analysis
Western blot analysis was performed as previously described [15] , with slight modifications. Proteins were extracted from the whole uterus or decidual endometrium by homogenization in RIPA buffer containing protease inhibitor cocktail (Sigma, St. Louis, MO). The homogenates were centrifuged at 48C. The supernatants were separated, and their protein concentrations were measured. The supernatants (50 lg of protein) were then boiled for 5 min in SDS sample buffer. The samples were run on 10% SDS-PAGE gels under reducing conditions and transferred onto Immobilon membranes (Millipore, Billerica, MA). Rabbit polyclonal antibody to TINAGL1 was prepared as described previously [7] , and its specificity was confirmed (Supplemental Fig.  S1 available at www.biolreprod.org). The membranes were incubated sequentially with 1% bovine serum albumin (BSA) in Tris-buffered salineTween 20, rabbit polyclonal antibody to TINAGL1, biotinylated goat antirabbit IgG (Zymed Laboratories, Inc., San Francisco, CA), and horseradish peroxidase (HRP)-conjugated streptavidin (Zymed Laboratories, Inc.). The HRP activity was visualized using 3,3 0 -diaminobenzidine tetrahydrochloride (DAB; Zymed Laboratories, Inc.). As the loading control, ACTB (also known as b-actin) was detected by sequential incubation with a monoclonal antibody to ACTB (Sigma), biotinylated goat anti-mouse IgG (Zymed Laboratories, Inc.), HRP-conjugated streptavidin, and DAB. Densitometric analysis of expression levels was performed using ImageJ software (version 1.37; National Institutes of Health, Bethesda, MD). Experiments were repeated five times.
Immunohistochemical Localization of TINAGL1, ITGA1, ITGA2, ITGA5, and ITGB1 in the Uterus During Peri-Implantation
Immunohistochemical analysis was performed as previously described [7, 16, 17] , with slight modifications. Frozen 10-lm sections from snap-frozen tissues were mounted onto silane-coated glass slides and stored at À808C until used. Sections were fixed in cold acetone on ice, immersed in 3% hydrogen peroxide in methanol, and treated with 1% BSA in PBS. For the primary antibody reaction, sections were incubated with rabbit polyclonal antibody to TINAGL1 or with goat polyclonal antibody to ITGA1, goat polyclonal antibody to ITGA2, rabbit polyclonal antibody to ITGA5, or rabbit polyclonal antibody to ITGB1 (all from Santa Cruz Biotechnology Inc., Santa Cruz, CA). After washing, sections were incubated with secondary antibodies; biotinylated goat anti-rabbit antibody for TINAGL1, ITGA5, and ITGB1; or biotinylated rabbit anti-goat antibody (Zymed Laboratories, Inc.) for ITGA1 and ITGA2. After incubation with HRP-conjugated streptavidin, reactions were visualized using 3-amino-9-ethyl carbazole (Zymed Laboratories, Inc.) as a chromogen, followed by counterstaining with hematoxylin. Reddish deposits indicate the sites of immunoreaction. Images shown are representative of at least six sections from more than three different animals for each stage. Experiments were repeated at least three times.
Biacore Analysis and Immunoprecipitation
Association between TINAGL1 and integrins was assessed by surface plasmon resonance (Biacore X instrument) and immunoprecipitation using whole uteri or decidual endometrium collected on Day 8 of pregnancy. Tissue lysates were prepared using lysis buffer (150 mM NaCl, 50 mM Tris-HCl at pH 8.0, 1% NP40, and protease inhibitor cocktail). Detection of integrins in the TINAGL1-binding protein was assessed using surface plasmon resonance with a Biacore X instrument as described previously [14, 18] , with slight modifications. As the running buffer, HBS-EP (0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% surfactant P20) containing 0.1% surfactant P20 (GE Healthcare Bio-Sciences KK) was used. The anti-TINAGL1 antibody was immobilized on a sensor chip CM5 (GE Healthcare Bio-Sciences KK) according to the manufacturer's instructions. Proteins were diluted to 50 lg/ml with running buffer containing NSB reducer (GE Healthcare Bio-Sciences KK). To detect the TINAGL1-protein complex, 50 ll of proteins was injected at a flow rate of 5 ll/min at 258C (first step). To confirm the presence of each integrin within the complex, 50 ll of antibodies to ITGA2, ITGA5, or ITGB1 was injected at a flow rate of 5 ll/min at 258C (second step). As negative controls for the proteins and the antibodies, BSA and normal IgG (goat or rabbit) were injected according to the manufacturer's instructions. The biosensor surface was regenerated with 5 ll of 10 mM glycine-HCl (pH 2.0) at a flow rate of 5 ll/min. Experiments were repeated three times for each integrin.
Immunoprecipitation was carried out using a Catch and Release Reversible Immunoprecipitation System (Millipore) according to the manufacturer's instructions. Using antibodies to ITGA5 or ITGB1 for 500 lg of tissue lysate, immunoprecipitation was performed overnight. As negative controls, normal rabbit IgG was used. Immunoprecipitates were separated by SDS-PAGE and transferred to Immobilon membranes. Membranes were incubated sequentially with rabbit polyclonal antibody to TINAGL1, peroxidase-labeled monoclonal mouse anti-rabbit light chain-specific IgG (Jackson ImmunoResearch, West Grove, PA), biotinylated goat anti-mouse IgG (Zymed Laboratories, Inc.), and HRP-conjugated streptavidin. The HRP activity was visualized using DAB. Experiments were repeated three times for each integrin.
Statistical Analysis
Levels of TINAGL1 protein were analyzed using one-way factorial ANOVA, followed by Fisher protected least significant difference test. P , 0.05 was considered significant.
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RESULTS
Expression of Tinagl1 mRNA and TINAGL1 Protein in the Uterus During the Peri-Implantation Period
Real-time RT-PCR was performed to determine the relative levels of Tinagl1 mRNA. The expression of Tinagl1 mRNA was low from Days 1 to 5 of pregnancy, while Tinagl1 mRNA levels increased from Days 6 to 8 (Fig. 1) . To determine the relative levels of TINAGL1 protein, Western blot analysis was performed, and a 52 3 10 À3 M r band was detected. As shown in Figure 2 , high expression of TINAGL1 protein was detected on Day 8 compared with Days 1-7. These data demonstrated that the levels of Tinagl1 mRNA and TINAGL1 protein were increased in postimplantation uteri.
Spatiotemporal Expression of TINAGL1 in the Uterus During the Peri-Implantation Period
To determine the localization of TINAGL1 expression, immunohistochemical analysis was performed. In uteri during the preimplantation period, TINAGL1 protein was seen in the basement membrane of luminal epithelium and glandular epithelium on Days 1 and 2 of pregnancy (Fig. 3, A-D) . In contrast, expression declined in the basement membrane of the luminal epithelium on Day 3 (Fig. 3, E and F) . On Day 4, very low levels of TINAGL1 protein were detected in the basement membrane of the luminal epithelium (Fig. 3, G and H) . On Day 5 following implantation, TINAGL1 protein was expressed in stromal blood vessels (Fig. 4A) . In contrast, on Days 6-8 during the postimplantation period, higher levels of TINAGL1 were present in the decidualized endometrium and sinuses (Fig.  4, B-D) . These observations demonstrated the robust expression of TINAGL1 protein in the decidua of postimplantation uteri.
Distribution of Integrins in the Uterus During the Preimplantation and Postimplantation Periods
TINAGL1 promotes cell adhesion and spreading through its role as a ligand for specific isotypes of integrin receptors [7] . Therefore, TINAGL1 may be associated with integrins in the peri-implantation uterus. To address this issue, immunohistochemical analysis was performed to examine the expression and localization of integrins. During the preimplantation period, there was variable expression of integrins on Day 1 of pregnancy, whereas we observed declined expression in the endometrium on Days 2-4 (Fig. 5) . On Day 1, high expression of ITGA1 was observed in the luminal epithelium and myometrium, although high ITGA2 expression was restricted to the luminal epithelium. Weak ITGA5 expression was observed in both the endometrium and the myometrium on Day 1. Although ITGB1 expression was observed in the myometrium, its expression was weak in the luminal epithelium on Day 1. Because integrins function as a dimer 
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of the alpha and beta subunits, these data demonstrated that the integrin receptor for TINAGL1 was not at a high level in the endometrium during the preimplantation period.
At postimplantation on Day 5, expression of ITGA1 and ITGB1 was observed around the decidual zone. The expression of ITGA2 was very low to undetectable in stromal cells, although ITGA5 was expressed weakly in the endometrium (Fig. 6 ). On Day 6, the pattern of ITGA1 expression was similar to that observed on Day 5, while the expression of ITGA2, ITGA5, and ITGB1 was low in stromal cells. In contrast, on Days 7 and 8, high expression of ITGA2, ITGA5, and ITGB1 was observed in stromal cells. ITGA5 and ITGB1 were expressed in decidual cells, while the expression of ITGA2 was mainly observed surrounding the implanted embryo.
Associations of TINAGL1 with ITGA5 and ITGB1 in the Decidua
Immunohistochemical analysis showed the possibility that ITGA2B1 and ITGA5B1 could be linked with TINAGL1 in decidual cells during the postimplantation period. To address this issue, we examined whether ITGA2, ITGA5, and ITGB1 bind with TINAGL1. At first, Biacore analysis was used as a rapid alternative to immunoprecipitation with anti-TINAGL1 antibody using an anti-TINAGL1 antibody coupled to Biacore sensor chips. Biacore analysis showed elevated signals, indicating TINAGL1 and TINAGL1-protein complex in tissue lysates from the whole implantation site in all cases (first step) (Fig. 7A) . To confirm the presence of integrin within the complex (second step), antibody for each integrin was injected. The injection of the antibodies against different integrins showed diverse reactions. Both antibodies against ITGA5 and ITGB1 showed increased signals (Fig. 7, A, C, and D) , although signals for ITGB1 were less (Fig. 7E) . In contrast, no signals were detected after injecting the anti-ITGA2 antibody (Fig. 7, A and B) . The relative resonance unit for the TINAGL1-integrin complex in the TINAGL1-protein complex demonstrated mean 6 SEM values of 38.7% 6 6.7% and 5.8% 6 5.2% for ITGA5 and ITGB1, respectively (Fig. 7E) . Immunoprecipitation with ITGA5 or ITGB1 on samples derived from the whole implantation site, followed by Western blotting to detect TINAGL1, demonstrated binding of TINAGL1 with both ITGA5 and ITGB1 (Fig. 7F) . Furthermore, examination of samples derived from isolated decidua also indicated that TINAGL1 bound with ITGA5 and ITGB1 (Fig. 7G) . These results demonstrated that TINAGL1 was the ligand for ITGA5B1 in the decidualized endometrium.
DISCUSSION
A previous study [7] using a cell culture system reported that TINAGL1 is a matricellular protein that interacts with both structural matrix proteins and cell surface receptors. However, the biological functions of Tinagl1 have not been well characterized. Our present investigation demonstrated that Tinagl1 is markedly expressed in the uterine decidua during postimplantation. In particular, TINAGL1 binds to integrin in the uterine decidua. These results suggest that TINAGL1 is related to the decidualization of uterine endometrium at postimplantation.
TINAGL1 promotes cell adhesion through its role as a ligand for ITGA1B1, ITGA2B1, and ITGA5B1 [7] . The present study demonstrated that TINAGL1 was widely expressed in the decidua of postimplantation uteri, while the expression of ITGA5 and ITGB1 was localized to the decidual cells close to the implanting embryo. In isolated decidua, TINAGL1 was linked with ITGA5 and ITGB1. The decidua provides nutritional support to the developing embryo before the establishment of a functional placenta and protects the embryo from the immunologic responses of the mother [3, 19] . These results suggest that TINAGL1 combined with ITGA5B1 is associated with uterine decidualization to support postimplantation embryonic development. 
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It has been reported that ITGA5-deficient mouse embryos start to show observable defects by Day 9 of gestation and die around Day 10 or 11 [20] , while mouse embryos lacking ITGB1 form normal blastocysts but fail to develop an inner cell mass and peri-implantation lethality [21] . Furthermore, the ligation of ITGA5B1 most efficiently strengthened blastocyst fibronectin-binding activity [22] . However, the function of ITGA5B1 in the mouse uterus is not well understood. The majority of studies of integrin-mediated signaling events have been performed on cells that adhere to fibronectin through ITGA5B1, which recognizes the tripeptide sequence Arg-GlyAsp. This association between ITGA5B1 and fibronectin is involved in regulating cell adhesion, migration, differentiation, and apoptosis [23, 24] . In addition to the findings that TINAGL1 promotes cell adhesion and spreading through its role as a ligand of ITGA5B1, TINAGL1 binds to extracellular matrix proteins such as fibronectin and collagens that are necessary for structural integrity [7] . In decidual cell cultures, constitutive levels of fibronectin are maintained to provide an extracellular framework to stabilize the decidual cytoskeleton and support morphological differentiation of decidual cells [25] . Therefore, TINAGL1-ITGA5B1 recognized by fibronectin may be associated with the decidualization of the endometrium during postimplantation.
We have previously demonstrated that TINAGL1 is an extraembryonic tissue-specific protein in mouse embryos during peri-implantation development [14] . In particular, TINAGL1 is a novel component of the Reichert membrane that interacts with laminin 1 [14] . During postimplantation development, the appropriate maintenance of the blastocyst cavity allows the Reichert membrane to form under the trophoblast cell layer. The Reichert membrane allows the efficient diffusion of gases and nutrients between the maternal blood in the yolk sac placenta and the embryo but protects the embryo from contact with the maternal immune system. It is likely that the morphogenesis of these structures requires stabilizing interactions between the trophoblast cells and the surrounding decidual cells [26] . Laminin 1 forms part of the basement membrane and the Reichert membrane [27, 28] . These results suggest that TINAGL1 combined with laminin 1 stabilizes the Reichert membrane to support early postimplantation embryonic developmental events. In contrast, our present results suggest that TINAGL1 combined with ITGA5B1 is associated with uterine decidualization. The decidua functions as nutritional support for embryonic development before the establishment of a functional placenta and protection of the embryo from maternal immunologic responses. Therefore, TINAGL1 most likely forms a barrier in both the maternal uterine decidua and the embryonic-derived Reichert membrane, while the compositional partners are different between TINAGL1 in the decidua and in the Reichert membrane.
During the postimplantation period, TINAGL1 was present in blood vessels and sinuses. In a previous study [7] , TINAGL1 was localized to the basal laminae along adrenocortical sinusoidal capillaries and surrounding vascular smooth muscle cells in the arterial system of the mouse. Furthermore, human TINAGL1 was also detected in vascular smooth muscles [29] . Considering the ability of TINAGL1 to promote cell adhesion and its preferential localization in vascular smooth muscle, it is proposed that this protein has a role in vascular systems through the modulation of cell-matrix interactions. Therefore, a possible role of uterine TINAGL1 is to support the structure and function of blood vessels and sinuses. While the expression of TINAGL1 was marked at the sinuses of postimplantation uteri, expression of ITGA5 and ITGB1 was much less in the   FIG. 7 . Detection of the TINAGL1-integrin complex in uterine tissue on Day 8 of pregnancy. A) Sensorgram readings of TINAGL1-integrin interactions using a Biacore X instrument. An anti-TINAGL1 antibody was coupled to Biacore sensor chips and exposed to whole implantation site tissue lysate to detect TINAGL1 and TINAGL1-protein complex (first step). The presence of integrins within the complex was then confirmed using polyclonal antibodies for ITGA2, ITGA5, or ITGB1 (second step). All experiments were repeated three times for each integrin, with similar results. B-D) Sensorgram readings of reactions with antibodies for integrins or IgG (second step). Subtracted readings (IgG from integrins) are represented in A. B) ITGA2 (dark green). C) ITGA5 (dark blue). D) ITGB1 (dark red). Gray lines show IgG. E) Relative response of integrin antibodies as a percentage of the value of tissue lysate against the immobilized anti-TINAGL1 antibody on the sensor chip described in A. Values are mean 6 SEM. F) Immunoprecipitation with integrin antibodies. Proteins extracted from whole implantation site were immunoprecipitated with anti-ITGA5 or anti-ITGB1 antibodies and then Western blotted with an antibody against TINAGL1. As a negative control, extracted proteins were precipitated with rabbit IgG. All experiments were repeated twice, with similar results. G) Immunoprecipitation for proteins extracted from decidua. Tissue lysates were immunoprecipitated with anti-ITGA5 or anti-ITGB1 antibodies and then Western blotted with an antibody against TINAGL1. As a negative control, extracted proteins were precipitated with rabbit IgG. All experiments were repeated three times, with similar results. RU, resonance unit; ND, not determined.
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269 region of sinusoidal vessels within the decidua basalis. Other compositional partners could be required for the function of TINAGL1 in the vascular systems of the uterine endometrium.
Numerous signaling molecules, including extracellular matrix remodeling factors, adhesion molecules, cytokines, homeobox transcription factors, cell cycle molecules, and lipid mediators, are involved in the decidualization of the endometrium. The present results demonstrate that TINAGL1 is a novel component of the decidualized endometrium during postimplantation. The decidua provides nutritional support for the development of embryos and protects the embryo from maternal immunology. In addition, a network of blood sinuses surrounding the embryo provides nutrients and oxygen by diffusion through the parietal yolk sac and the Reichert membrane. Therefore, the present results suggest that TINAGL1 is associated in part with endometrial function to support embryonic development, although the compositional partners of TINAGL1 will depend on the cell type. These results may help to elucidate the distinct role of the endometrial cells for embryonic development during postimplantation, although determination of the definitive role of TINAGL1 during early pregnancy will require further studies involving the deletion of this gene.
